Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Alkermes plc. Director's Dealing 2011

Sep 20, 2011

31048_dirs_2011-09-20_0790a036-35ef-480a-b476-41beb6d49388.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Alkermes plc. (ALKS)
CIK: 0001520262
Period of Report: 2011-09-16

Reporting Person: Ehrich Elliot (SVP, R&D & CMO, Alkermes, Inc.)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-09-16 Common Stock A 18579 Acquired 18579 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-09-16 Incentive Stock Option (Right to Buy) $19.40 A 5157 Acquired 2011-10-02 Common Stock (5157) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $19.40 A 69843 Acquired 2011-10-02 Common Stock (69843) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $14.57 A 25269 Acquired 2013-10-17 Common Stock (25269) Direct
2011-09-16 Incentive Stock Option (Right to Buy) $14.57 A 1731 Acquired 2013-10-17 Common Stock (1731) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $12.16 A 44500 Acquired 2013-12-10 Common Stock (44500) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $12.30 A 22500 Acquired 2014-07-12 Common Stock (22500) Direct
2011-09-16 Incentive Stock Option (Right to Buy) $12.30 A 7500 Acquired 2014-07-12 Common Stock (7500) Direct
2011-09-16 Incentive Stock Option (Right to Buy) $14.90 A 520 Acquired 2014-12-17 Common Stock (520) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $14.90 A 70980 Acquired 2014-12-17 Common Stock (70980) Direct
2011-09-16 Incentive Stock Option (Right to Buy) $18.60 A 5376 Acquired 2015-12-09 Common Stock (5376) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $18.60 A 32624 Acquired 2015-12-09 Common Stock (32624) Direct
2011-09-16 Incentive Stock Option (Right to Buy) $20.79 A 4687 Acquired 2016-05-02 Common Stock (4687) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $20.79 A 14063 Acquired 2016-05-02 Common Stock (14063) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $14.38 A 20323 Acquired 2016-12-12 Common Stock (20323) Direct
2011-09-16 Incentive Stock Option (Right to Buy) $14.38 A 177 Acquired 2016-12-12 Common Stock (177) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $15.95 A 23731 Acquired 2017-06-01 Common Stock (23731) Direct
2011-09-16 Incentive Stock Option (Right to Buy) $15.95 A 6269 Acquired 2017-06-01 Common Stock (6269) Direct
2011-09-16 Employee Stock Option (Right to Buy) $14.13 A 15000 Acquired 2017-11-05 Common Stock (15000) Direct
2011-09-16 Employee Stock Option (Right to Buy) $12.29 A 45000 Acquired 2018-05-27 Common Stock (45000) Direct
2011-09-16 Employee Stock Option (Right to Buy) $8.55 A 65000 Acquired 2019-05-26 Common Stock (65000) Direct
2011-09-16 Restricted Stock Award $0 A 4250 Acquired Common Stock (4250) Direct
2011-09-16 Employee Stock Option (Right to Buy) $9.21 A 40000 Acquired 2019-11-18 Common Stock (40000) Direct
2011-09-16 Restricted Stock Award $0 A 15000 Acquired Common Stock (15000) Direct
2011-09-16 Employee Stock Option (Right to Buy) $11.74 A 115800 Acquired 2020-05-17 Common Stock (115800) Direct
2011-09-16 Restricted Stock Unit Award $0 A 12525 Acquired Common Stock (12525) Direct
2011-09-16 Employee Stock Option (Right to Buy) $18.105 A 100000 Acquired 2021-05-20 Common Stock (100000) Direct
2011-09-16 Restricted Stock Unit Award $0 A 15000 Acquired Common Stock (15000) Direct

Footnotes

F1: Received in exchange for shares of Alkermes, Inc. common stock in connection with the merger of Alkermes, Inc. and the global drug delivery technologies business of Elan (the "Merger"). On 9/16/11, the effective date of the Merger, the closing price of ALKS was $16.57 per share.

F2: These options are fully vested in accordance with their terms.

F3: Received in exchange for, and having substantially the same terms as, stock options of Alkermes, Inc. common stock in connection with the Merger.

F4: 75% vested as of 9/16/11, remainder vests on 11/5/11.

F5: 75% vested as of 9/16/11, remainder vests on 5/27/12.

F6: 50% vested as of 9/16/11, remainder vests in 2 equal annual installments beginning on 5/26/12.

F7: Received in exchange for, and having substantially the same terms as, restricted stock unit awards of Alkermes, Inc. common stock in connection with the Merger.

F8: 25% vested as of 9/16/11, remainder vests in 3 equal annual installments beginning on 11/18/11.

F9: 25% vested as of 9/16/11, remainder vests in 3 equal annual installments beginning on 5/17/12.

F10: Vests in 4 equal annual installments beginning on 5/20/12.